z-logo
Premium
Cardiac Cell Hypertrophy In Vitro
Author(s) -
Colella Matilde,
Pozzan Tullio
Publication year - 2008
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1420.008
Subject(s) - nfat , medicine , endocrinology , calcineurin , muscle hypertrophy , receptor , chemistry , in vitro , angiotensin ii , microbiology and biotechnology , biophysics , biology , biochemistry , transplantation
Various conditions were used to investigate the importance of Ca 2+ signaling in triggering hypertrophy in neonatal rat cardiomyocytes in vitro . An increase in cell size and sarcomere reorganization were induced not only by treatment with receptor agonists, such as angiotensin II, aldosterone, and norepinephrine, but also by a small depolarization caused by an increase in the KCl concentration of the medium. This latter treatment has no direct effects on receptor signaling. All these hypertrophic treatments caused a long‐lasting increase in the frequency of spontaneous [Ca 2+ ] oscillations, causing nuclear translocation of transfected NFAT (GFP). Cyclosporine A inhibited hypertrophy and NFAT translocation, but not the increased oscillation frequency. We propose here that calcineurin–NFAT can act as integrators of the Ca 2+ signal and can decode alterations in the frequency even of very rapid Ca 2+ oscillations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom